Services:
- Consumer fraud litigation
- Securities fraud litigation
- ERISA litigation
- Products liability and mass torts litigation
- Derivative and corporate governance litigation
- Corporate mismanagement
- Diversion of funds
- Fraud
- Self-dealing
- Conflicts of interest
- Breach of fiduciary duty
- Human rights/civil rights litigation
- Environmental litigation
- Antitrust litigation
|
|
Class actions have soared in the last decade, and today they represent significant litigation risks for companies with large numbers of shareholders or customers. Derivative litigation aimed at officers and directors of corporations also presents substantial challenges to corporate governance and threatens them with personal liability for breach of fiduciary duty. Identified as a top litigation practice by Chambers USA: America’s Leading Lawyers for Business, Lowenstein Sandler has a nationally-recognized Class Action & Derivative Litigation Group. We have litigated a wide array of class actions and putative class actions in the federal and state courts of New York and New Jersey.
The class action matters we handle include consumer fraud, securities fraud, ERISA, antitrust, products liability, and mass tort claims. While our attorneys advise clients on avoiding or mitigating class action exposure, litigation often is inevitable. We are adept in the procedural law and strategy of class actions and win substantive legal rulings that limit or eliminate the exposure to companies of such actions. The firm’s Class Action & Derivative Litigation Group also frequently is called on to defend derivative litigation, brought against public and private companies and their directors and officers. Guided by our clients’ business objectives, we develop and implement strategic litigation plans tailored to the facts, jurisdiction, and specific demands of each situation.
Government regulatory schemes affecting particular industries often play a significant role in the outcomes of class actions and derivative litigation and contribute to the complexities of the case. We have become well-versed in these complexities by immersing ourselves in the major regional industries at risk in class action lawsuits, such as pharmaceuticals, medical devices, public utilities, financial services, and telecommunications. We leverage this knowledge to achieve the best possible results in seemingly dire situations—results that include restored reputations and continued business success.
Practice Details
|